ArticleBMC medical informatics and decision making2026
Dual-path deep learning framework for accurate and interpretable brain tumor diagnosis.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brain Tumor Segmentation and Grading on MRI Using Deep Learning: A Systematic Literature Review and Benchmark-Driven Comparative Analysis.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Existing frameworks for brain tumor diagnosis often focus on standalone classification or retrieval tasks, limiting clinical interpretability and failing to leverage complementary diagnostic insights. To address this, we propose a novel dual-path deep learning framework that synergistically integrates tumor classification with content-based image retrieval (CBIR). Our approach uniquely combines a lightweight GhostNetV3 backbone with deformable convolutions and a decoupled fully connected (DFC) attention mechanism to simultaneously optimize feature extraction for both tasks. This integration enables dynamic adaptation to irregular tumor morphologies while retrieving visually similar cases, bridging the gap between automated predictions and actionable clinical context. Evaluated on a public T1-weighted contrast-enhanced MRI dataset (233 patients, 3,064 images), the framework achieves state-of-the-art performance: 99.71% classification accuracy (precision/recall/F1 > 0.99) and 97.74% mean average retrieval precision (Prec@10: 99.78%). We further introduce the Classification-Retrieval Agreement Score (CRAS), a novel metric quantifying alignment between classifier predictions and retrieved cases, with a mean score > 0.96 demonstrating robust diagnostic consistency. By enhancing accuracy, interpretability, and computational efficiency, this work advances the clinical viability of AI-driven brain tumor diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.